Lumpectomy and partial breast irradiation for early-stage breast cancer following mantle irradiation for Hodgkin's lymphoma

Nature Clinical Practice Oncology

Volumn 5, Issue 7, 2008, Pages 426-429

  Alm El Din, Mohamed A ^a   Feng, Jennifer K ^a   Taghian, Alphonse G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LETROZOLE; PROGESTERONE RECEPTOR; TAMOXIFEN; THYROXINE; VINBLASTINE;

ADULT; ANAMNESIS; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED RADIOTHERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOMAMMOGRAPHY; ERYTHEMA; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; MANTLE FIELD RADIOTHERAPY; MASTECTOMY; MEDICAL DECISION MAKING; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SENTINEL LYMPH NODE BIOPSY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TREATMENT REFUSAL; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HODGKIN DISEASE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; RISK FACTORS;

EID: 46949086524     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc1135     Document Type: Article

References (15)

1. Yahalom J et al. (1992) Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 10: 1674-1681
2. Wolden SL et al. (2000) Management of breast cancer after Hodgkin's disease. J Clin Oncol 18: 765-772
3. Taghian AG et al. (2006) Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 64: 1092-1099
4. Hancock SL et al. (1993) Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85: 25-31
5. Aleman BM et al. (2003) Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med 348: 2396-2406
6. Aisenberg AC et al. (1997) High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 79 1203-1210
7. Wahner-Roedler DL et al. (2003) Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience. Mayo Clin Proc 78: 708-715
8. van Leeuwen FE et al. (2000) Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18: 487-497
9. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists (1998) Breast radiotherapy after breast-conserving surgery. CMAJ 158 (Suppl 3): S35-S42
10. Aref I and Cross P (2000) Conservative surgery and radiation therapy for early stage breast cancer after previous mantle radiation for Hodgkin's disease. Br J Radiol 73: 905-906
11. Deutsch M et al. (2001) Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphoma. Am J Clin Oncol 24: 33-34
12. Intra M et al. (2005) A new option for early breast cancer patients previously irradiated for Hodgkin's disease: Intraoperative radiotherapy with electrons (ELIOT). Breast Cancer Res 7: R828-R832
13. Sanna G et al. (2007) Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors. Ann Oncol 18: 288-292
14. Hiatt JR et al. (2006) Dose-modeling study to compare external beam techniques from protocol NSABP B-39/RTOG 0413 for patients with highly unfavorable cardiac anatomy. Int J Radiat Oncol Biol Phys 65: 1368-1374
15. Vicini F et al. (2005) A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I/II breast carcinoma: Initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys 63: 1531-1537